期刊文献+

多重耐药铜绿假单胞菌整合子和ISCR1结构及基因分型研究 被引量:1

Study on multi drug resistant Pseudomonas aeruginosa integron and ISCR1 structure and genotyping
下载PDF
导出
摘要 目的:研究临床分离的铜绿假单胞菌的整合子I和ISCRl的分布情况,并进行ERIC-PCR基因分型。方法:分离临床80株铜绿假单胞菌,ERIC-PCR进行基因分型。PCR检测整合酶I、整合子I、ISCRl以及ISCRl携带的耐药基因。结果:铜绿假单胞菌分为51个基因型,26株整合酶阳性,21株整合子I阳性,2株ISCR1和ISCR1携带的耐药基因阳性。结论:铜绿假单胞菌的整合子I和ISCRI携带率较低,临床可用ERIC-PCR进行铜绿假单胞菌的基因分型。 Objective: To investigate the distribution of class I integrin and ISCR1 in Pseudomonas aeruginosa isolated from clinical species and evaluate the genetic relatedness of these isolates. Methods: Eighty Pseudomonas aeruginosa were isolated. ERIC- PCR was determined for genotype of these isolates. Class I integrin, class I integrase, ISCR1 and antibiotic resistance genes carried by ISCR1 were performed by PCR. Results: There were 51 genotypes in isolated Pseudomonas aeruginosa. 26 class I integrase positive, 21 class I integrons positive, 2 ISCRI and 2 resistance genes carried by ISCR1 were detected. Conclusions: Class I integrin and ISCRI were low in Pseudomonas aeruginosa. ERIC-PCR is convenient and effective for genotyping of clinical Pseudomonas aeruginosa.
作者 王卓 王修银 赖沛炼 区焕桃 WANG Zhuo WANG Xiu-yin LAI Pei-lian et al(Department of clinical laboratory,TCM hospital of Guang zhou city, Guang dong Guang zhou 510130)
出处 《医学检验与临床》 2017年第2期20-22,47,共4页 Medical Laboratory Science and Clinics
关键词 铜绿假单胞菌 整合子 ISCR1 ERIC-PCR Pseudomonas aeruginosa Integrin ISCR1 ERIC-PCR
  • 相关文献

参考文献1

二级参考文献11

  • 1Walkty A, DeCorby M, Nichol K, et al, Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study[J]. Diagn Microbiol Infect Dis, 2008, 61:217-221.
  • 2Zavascki A P, Carvalhaes resistant Pseudomonas C G, Picao R C, et al. Multidrugaeruginosa and Acinetobacter baumannii: Resistance mechanisms and implications for therapy[J]. Expert Rev Anti Infect Ther, 2010,8(1):71-93.
  • 3Paterson D L. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis, 2006, 43:S43-S48.
  • 4Suairez C, Pefia C, Tubau F, et al. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections[J]. Jlnfect, 2009, 58:285-290.
  • 5Wang H, Chen M J, Ni Y X, et al. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003-2008[J]. lnt JAntimicrob Agents, 2010, 35: 227-234.
  • 6Hirsch E B, Tam V H. Pseudomonas aeruginosa infection on patient outcomes[J]. Expert Rev Pharmacoeeonom Outcomes Res, 2010, 10(4): 441-451.
  • 7Aloush V, Venezia S N, Igra Y S, et al. Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact[J]. Antimicrob Agents Chemother, 2006, 50(1): 43-48.
  • 8Cardoso O, Alves A F, Leitao R. Surveillance of antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates from a central hospital in Portuga[J]. J Antimicrob Agents, 2007, 60(2): 452-454.
  • 9Pakyz A L, Oinonen M, Polk R E, et al. Relationship of carbapenem restriction in 22 university teaching hospital to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 2009, 53(5): 1983-1986.
  • 10Kaleem F, Usman J, Hassan A, et al. Frequency and susceptibility pattern of metallo-beta-lactamase producers in a hospital in Pakistan[J]. Jlnfect Dev Ctries, 2010, 4(12): 810-813.

共引文献40

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部